Bruker Corporation
BRKR
Rang in Aktien
#2332
Bruker Corporation stands as a prominent global developer, manufacturer, and... Bruker Corporation stands as a prominent global developer, manufacturer, and distributor of cutting-edge scientific instruments, alongside comprehensive analytical and diagnostic solutions. Its operations are structured across three distinct segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. The company's extensive portfolio for life sciences encompasses a variety of advanced tools, including single and multi-modality systems, sophisticated mass spectrometry platforms, and critical diagnostic solutions. These diagnostics feature the acclaimed MALDI Biotyper for swift pathogen identification, various molecular diagnostic kits (such as genotype and fluorotype offerings), DNA test strips, and fluorescence-based polymerase chain reaction (PCR) technology, notably including SARS-CoV-2 testing solutions for COVID-19 diagnosis and Fluorotyper-SARS-CoV-2 plus kits. Beyond life science, Bruker delivers a wide array of specialized instruments for research, analysis, and process control. This includes portable analytical and bioanalytical detection systems, a full range of X-ray instruments (from analytical tools for electron microscopes to handheld, portable, and mobile X-ray fluorescence spectrometry devices), and sophisticated atomic force microscopy (AFM) instrumentation for non-contact nanometer resolution topography. Furthermore, it supplies automated X-ray metrology, automated AFM defect-detection, and equipment for photomask repair and cleaning. The company also excels in advanced optical fluorescence microscopy and provides critical products and services supporting multi-omics research for drug and biomarker discovery. Within its energy sector, Bruker is a key provider of superconducting materials, particularly metallic low-temperature superconductors, and develops complex tools and devices utilizing these materials, alongside other high-technology tools like synchrotron and beamline instrumentation. Reflecting its commitment to innovation, Bruker Corporation collaborates with Newomics Inc. on an LC-MS platform specifically tailored for drug discovery applications. Established in 1991, the corporation maintains its headquarters in Billerica, Massachusetts.
Aktienkurs
$55.38
Zuletzt synchronisiert: 2026-10-19
Marktkapitalisierung
$8.44B
Veränderung (1 Tag)
1.05%
Veränderung (1 Jahr)
45.30%
Land
US
Handel Bruker Corporation (BRKR)
Kategorie
Healthcare
Anzahl der ausstehenden Aktien von Bruker Corporation (BRKR)
Anzahl der ausstehenden Aktien zum June 2026: 152.20M
Laut den neuesten Finanzberichten und dem Aktienkurs von Bruker Corporation beträgt die aktuelle Anzahl der ausstehenden Aktien 152.20M. Am Ende von December 2024 hatte das Unternehmen 149.00M ausstehende Aktien. Die Anzahl der ausstehenden Aktien wird normalerweise durch Aktiensplits und Aktienrückkäufe beeinflusst.
Verlauf der ausstehenden Aktien von Bruker Corporation (BRKR) von 2000 bis 2026
Ausstehende Aktien am Ende jedes Jahres
| Jahr | Ausstehende Aktien | ändert |
|---|---|---|
| 2026 (TTM) | 152.20M | 0.26% |
| 2025 | 151.80M | 1.88% |
| 2024 | 149.00M | 1.78% |
| 2023 | 146.40M | -1.48% |
| 2022 | 148.60M | -1.85% |
| 2021 | 151.40M | -1.30% |
| 2020 | 153.40M | -1.16% |
| 2019 | 155.20M | -0.64% |
| 2018 | 156.20M | -1.20% |
| 2017 | 158.10M | -2.04% |
| 2016 | 161.40M | -4.04% |
| 2015 | 168.20M | 0.24% |
| 2014 | 167.80M | 0.78% |
| 2013 | 166.50M | 0.30% |
| 2012 | 166.00M | 0.36% |
| 2011 | 165.40M | 0.61% |
| 2010 | 164.40M | 0.55% |
| 2009 | 163.50M | 0.49% |
| 2008 | 162.70M | 0.93% |
| 2007 | 161.20M | 58.80% |
| 2006 | 101.51M | 0.68% |
| 2005 | 100.82M | 4.62% |
| 2004 | 96.38M | -6.67% |
| 2003 | 103.26M | 96.31% |
| 2002 | 52.60M | -2.70% |
| 2001 | 54.06M | -3.89% |
| 2000 | 56.25M | 0.00% |
Ausstehende Aktien bei ähnlichen Unternehmen oder Wettbewerbern
| Unternehmen | Ausstehende Aktien | Unterschied | Land |
|---|---|---|---|
| 1.74B | 1,045.24% |
US
|
|
| 1.28B | 742.38% |
IE
|
|
| 383.50M | 151.97% |
US
|
|
| 1.48B | 870.83% |
US
|
|
| - | - |
DE
|
